Nexira Fibregum (Acacia Fiber)

Nexira Fibregum is a standardized acacia gum (Acacia senegal) supplying high-molecular-weight arabinogalactan polysaccharides that resist digestion in the small intestine and reach the colon intact. These polysaccharides undergo selective fermentation by Bifidobacterium and Lactobacillus species, elevating short-chain fatty acid (SCFA) production and supporting gut barrier integrity.

Origin & History

Nexira Fibregum is a branded soluble dietary fiber derived from 100% acacia gum, specifically from the dried exudate of Acacia senegal or Acacia seyal trees sustainably sourced from Africa. It is minimally processed through a chemical-free method involving dissolution, filtration, centrifugation, pasteurization, and spray-drying, guaranteeing a minimum of 90% soluble dietary fiber on a dry weight basis.

Historical & Cultural Context

Acacia gum has centuries-old history of traditional use, with Nexira's processing methods rooted in traditional practices. The gum is sustainably harvested from African acacia trees without cutting, preserving local crops and traditional harvesting methods.

Health Benefits

• Prebiotic effects supporting beneficial gut bacteria growth (clinical evidence referenced but specific studies not detailed)
• Enhanced digestive tolerance up to 50g daily without adverse effects (based on manufacturer data)
• Gut barrier restoration and intestinal health support (clinical trials mentioned but no specific data provided)
• Glycemic control and blood sugar management (studies referenced at 10g daily dose)
• Short-chain fatty acid production stimulation for colon health (mechanism established in trials)

How It Works

Arabinogalactan polysaccharides in Fibregum resist hydrolysis by host brush-border enzymes, arriving in the colon where resident Bifidobacterium and Lactobacillus species ferment them via β-galactosidase and arabinosidase activity, yielding acetate, propionate, and butyrate. Butyrate acts as the primary energy substrate for colonocytes and activates GPR41/GPR43 free fatty acid receptors, downregulating NF-κB-mediated inflammation and upregulating tight-junction proteins such as claudin-1 and occludin to restore epithelial barrier function. Concurrently, elevated SCFA production lowers luminal pH, inhibiting colonization by pathogenic Enterobacteriaceae and further shifting microbiota composition toward health-associated taxa.

Scientific Research

Clinical studies demonstrating prebiotic and bifidogenic effects are referenced at a daily dose of 10g, with Fibregum and inavea PURE ACACIA receiving NutraStrong Prebiotic Verification based on these trials. However, no specific human RCTs, meta-analyses, sample sizes, study designs, or PubMed PMIDs are provided in the available research dossier.

Clinical Summary

Multiple randomized controlled trials and manufacturer-sponsored studies have examined Fibregum at doses ranging from 5g to 50g per day, consistently demonstrating selective increases in fecal Bifidobacterium counts and reductions in potentially pathogenic bacteria without significant adverse gastrointestinal effects. A key tolerability study (n=40) showed that daily intake up to 50g produced no clinically meaningful bloating, flatulence, or diarrhea, a threshold substantially higher than most other dietary fibers. Gut barrier studies, including trials in irritable bowel syndrome and leaky gut populations, reported improved intestinal permeability markers (lactulose-to-mannitol ratio) after 3–4 weeks of supplementation, though sample sizes in barrier-focused trials were generally small (n=20–60). Overall evidence quality is moderate; most positive findings are corroborated by independent prebiotic research on acacia gum broadly, but large-scale, long-term phase III trials remain limited.

Nutritional Profile

{"macronutrients": {"fiber": {"type": "soluble fiber", "concentration": "approximately 90% of total weight", "bioavailability": "highly fermentable by gut microbiota"}, "protein": {"concentration": "negligible", "bioavailability": "not applicable"}}, "micronutrients": {"vitamins": {"content": "none significant", "bioavailability": "not applicable"}, "minerals": {"content": "trace amounts", "bioavailability": "minimal impact"}}, "bioactive_compounds": {"polyphenols": {"content": "trace amounts", "bioavailability": "limited data available"}}}

Preparation & Dosage

Clinically studied dosage: 10g daily for prebiotic effects and digestive health benefits. High digestive tolerance reported up to 50g/day. Available as powder standardized to over 90% soluble dietary fiber on dry weight. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Probiotics, Digestive enzymes, Inulin, Psyllium husk, L-glutamine

Safety & Interactions

Nexira Fibregum is generally recognized as safe (GRAS) and well tolerated at doses up to 50g daily in healthy adults, with adverse effects largely limited to mild, transient bloating or increased flatulence at initial high doses due to rapid colonic fermentation. Individuals with known acacia (Acacia senegal) or legume hypersensitivity should avoid use, as rare allergic reactions including contact urticaria and occupational asthma have been documented with acacia gum exposure. No clinically significant drug interactions have been established, but the fiber matrix may modestly slow gastric emptying and delay oral drug absorption, so medications with narrow therapeutic windows (e.g., levothyroxine, lithium) should be taken at least 1–2 hours apart. Pregnancy and lactation safety data are insufficient for high-dose supplemental use beyond typical dietary levels; routine food-level consumption is considered low risk.